The META tool is an affordable platform developed by NICE to help MedTech innovators understand what evidence is needed to make a convincing case to payers and commissioners for their technology. JB Medical is now licensed to support innovators to use the tool to identify ways to optimise their technology development plans, and to identify potential next steps for bringing their technology to market.
If you are a MedTech innovator wishing to understand how your R&D plans could be optimised, how strong your technology’s clinical and cost-effectiveness evidence bases are, or how your route to market could be accelerated, get in touch with JB Medical’s META facilitator Dr Melissa Kapoor (email).
JB Medical offers three levels of META service: Basic, Standard and Full. This means there is a service available for every budget and every stage of a technology’s stage of development.
We are experts in MedTech market access, having supported more than 300 MedTech companies with a wide range of market access services, including health economics (including pricing and building sales tools), clinical trial design and evaluation, systematic literature review and NICE MTEP and HTA preparation.
Hot off the press
We've just published a paper in the Journal of Medical Economics showing that adding the Parkinson’s KinetiGraph (the PKG, a wrist-worn movement recording device that collates continuous, objective, data during daily activities in people with Parkinson’s disease (PD) providing a report for clinicians) to standard monitoring of PD is a cost-effective option.